Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Mehta

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Plos One|October 3, 2012
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growthYi Liu, Dianna Howard, Kyle Rector, et al.
JACC. Case Reports|December 18, 2024
Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving TeclistamabAlexander Hurtado, Samuel T Luebbe, Emma Kilbane, et al.
JAAD Case Reports|December 21, 2020
Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoidesChristina J Walker, Eric D Donnelly, Jonathan Moreira, et al.
Leukemia Research|December 17, 2011
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemiaSteven M Trifilio, Alfred W Rademaker, Diane Newman, et al.
Transfusion|January 28, 2009
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studiesJunya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 12, 2017
Olanzapine Reduces Chemotherapy-induced Nausea and Vomiting Compared With Aprepitant in Myeloma Patients Receiving High-dose Melphalan Before Stem Cell Transplantation: A Retrospective StudySteven Trifilio, Colleen Welles, Kristin Seeger, et al.
JACC. Cardiooncology|April 22, 2026
Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody TherapyEli Grunblatt, Sawsan A Alkhalili, Zhiying Meng, et al.
Leukemia & Lymphoma|December 5, 2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotypeBhawna Sirohi, Ray Powles, Seema Singhal, et al.
Blood|December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyAsher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Echocardiography (Mount Kisco, N.Y.)|May 14, 2013
Cardiac device-related invasive aspergilloma assessed by live/real time three-dimensional transthoracic echocardiographyDonald Clark, Mustafa I Ahmed, Aylin Sungur, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Plos One|October 3, 2012
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growthYi Liu, Dianna Howard, Kyle Rector, et al.
JACC. Case Reports|December 18, 2024
Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving TeclistamabAlexander Hurtado, Samuel T Luebbe, Emma Kilbane, et al.
JAAD Case Reports|December 21, 2020
Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoidesChristina J Walker, Eric D Donnelly, Jonathan Moreira, et al.
Leukemia Research|December 17, 2011
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemiaSteven M Trifilio, Alfred W Rademaker, Diane Newman, et al.
Transfusion|January 28, 2009
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studiesJunya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 12, 2017
Olanzapine Reduces Chemotherapy-induced Nausea and Vomiting Compared With Aprepitant in Myeloma Patients Receiving High-dose Melphalan Before Stem Cell Transplantation: A Retrospective StudySteven Trifilio, Colleen Welles, Kristin Seeger, et al.
JACC. Cardiooncology|April 22, 2026
Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody TherapyEli Grunblatt, Sawsan A Alkhalili, Zhiying Meng, et al.
Leukemia & Lymphoma|December 5, 2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotypeBhawna Sirohi, Ray Powles, Seema Singhal, et al.
Blood|December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyAsher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Echocardiography (Mount Kisco, N.Y.)|May 14, 2013
Cardiac device-related invasive aspergilloma assessed by live/real time three-dimensional transthoracic echocardiographyDonald Clark, Mustafa I Ahmed, Aylin Sungur, et al.
Pageof 11